Novoheart Holdings Company
Novoheart is committed to providing state-of-the-art stem cell and bioengineering approaches to revolutionize drug discovery.
Funding Status:
IPO
Industry:
Preclinical Development
Technology:
Biotechnology, Pharmaceutical
Headquarters:
Vancouver, Alberta, Canada
Employee Number:
51-100
Founded Date:
1964-01-01